 - Administration of immune globulin or other blood products within the last three months, or injected or oral corticosteroids or other immunomodulator therapy within six weeks of the study vaccine. Individuals on a tapering dose schedule of oral steroids lasting 7 days may be included in the trial as long as they have not received more than one course within the last two weeks prior to enrollment. 